Burd G S, Chirkova L D, Sheliakina L A
Zh Nevropatol Psikhiatr Im S S Korsakova. 1980;80(12):1804-8.
In 42 patients with ischemic cerebral stroke, the state of the kallikrein-kinin system of the blood was analyzed by three main parameters: total esterase activity, prekallikrein content, and activity of the kallikrein inhibitor. Two blood specimens were taken (from the femoral artery and the superior bulb of the internal jugular vein) at the peak of the stroke acute period. An activation of the kallikrein-kinin system was revealed, the degree of which was found to depend on the gravity of the pathological process in the brain. At the initial stages of the disease a moderate activation of the kallikrein-kinin system was noted, the fact, that was, probably, favourable for improvement of the blood circulation. Possible pathogenetic mechanisms (hypoxia, lowering of the medium pH, etc.) of the system activation are discussed. For treating patients who were in a soporous-comatose state with a sharp drop of the kallikrein activity in the cerebral venous blood it was recommended to use drugs blocking the excess formation of kinins. At the initial stage of the disease development such an intervention should be regarded undesirable.
对42例缺血性脑卒患者,通过三个主要参数分析了血液中激肽释放酶 - 激肽系统的状态:总酯酶活性、前激肽释放酶含量以及激肽释放酶抑制剂的活性。在脑卒中急性期高峰时采集两份血样(分别来自股动脉和颈内静脉上球部)。结果显示激肽释放酶 - 激肽系统被激活,其激活程度取决于脑部病理过程的严重程度。在疾病初期,观察到激肽释放酶 - 激肽系统有中度激活,这一事实可能有利于改善血液循环。文中讨论了该系统激活可能的发病机制(缺氧、介质pH降低等)。对于处于昏睡 - 昏迷状态且脑静脉血中激肽释放酶活性急剧下降的患者,建议使用能阻断激肽过量生成的药物进行治疗。在疾病发展的初期阶段,这种干预应被视为不可取。